Page last updated: 2024-09-03

troxacitabine and Adenocarcinoma Of Kidney

troxacitabine has been researched along with Adenocarcinoma Of Kidney in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belanger, K; Bjarnason, GA; Chi, K; Ernst, DS; Goel, R; Jolivet, J; McIntosh, L; Moore, MJ; Ruether, JD; Seymour, L; Siu, LL; Stewart, D; Tannock, I; Townsley, CA1
Angers, EG; Attardo, G; Bednarski, K; Bibeau, L; Bowlin, TL; Cimpoia, A; DeMuys, JM; Kadhim, SA; Waud, WR1

Trials

1 trial(s) available for troxacitabine and Adenocarcinoma Of Kidney

ArticleYear
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Apr-15, Volume: 21, Issue:8

    Topics: Aged; Antineoplastic Agents; Canada; Carcinoma, Renal Cell; Cytosine; Dioxolanes; Disease Progression; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Treatment Outcome

2003

Other Studies

1 other study(ies) available for troxacitabine and Adenocarcinoma Of Kidney

ArticleYear
Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
    Cancer research, 1997, Nov-01, Volume: 57, Issue:21

    Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cytosine; Dioxolanes; Drug Screening Assays, Antitumor; Female; Humans; Kidney Neoplasms; Mice; Neoplasm Transplantation; Nucleosides; Transplantation, Heterologous; Tumor Cells, Cultured

1997